Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM), a main cardiovascular complication of diabetes, can eventually develop into heart failure and affect the prognosis of patients. Myocardial fibrosis is the main factor causing ventricular wall stiffness and heart failure in DCM. Early control of myocardial fibrosis in D...
Main Authors: | Yanan Cheng, Yan Wang, Ruili Yin, Yongsong Xu, Lijie Zhang, Yuanyuan Zhang, Longyan Yang, Dong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1162754/full |
Similar Items
-
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
by: Maja Schlittler, et al.
Published: (2023-10-01) -
Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis
by: Maria Raquel Moita, et al.
Published: (2022-12-01) -
An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy
by: Ayman M. Ibrahim, et al.
Published: (2020-09-01) -
Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair
by: Luke R. Perreault, et al.
Published: (2024-02-01) -
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
by: Patrício Aguiar, et al.
Published: (2018-03-01)